Cargando…
Bevacizumab inhibits proliferation of choroidal endothelial cells by regulation of the cell cycle
BACKGROUND: The purpose of this study was to evaluate cell cycle changes in choroidal endothelial cells treated with varying doses of bevacizumab in the presence of a range of concentrations of vascular endothelial growth factor (VEGF). Bevacizumab, a drug widely used in the treatment of neovascular...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575188/ https://www.ncbi.nlm.nih.gov/pubmed/23430458 http://dx.doi.org/10.2147/OPTH.S41556 |